BrainStorm Files Patent Application for Stem Cell Procedure With Potential for Multiple Sclerosis Therapy NEW YORK and TEL AVIV, Israel, Jan. 26, 2006 (PRIMEZONE) -- BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(tm) bone marrow derived stem cell therapeutic products for the treatment...

Dr. Rob Shorr of BrainStorm Cell Therapeutics, Inc. to be Featured Guest on Corporate Strategies Radio Show NEW YORK and TEL AVIV, Israel, Jan. 5, 2006 (PRIMEZONE) -- BrainStorm Cell Therapeutics, Inc. (OTCBB:BCLI) will be one of the featured companies on the Corporate Strategies Radio Show, airing Sunday...

BrainStorm Makes Progress Towards Human Stem Cell Therapy for Parkinson's NEW YORK and TEL AVIV, Israel, Dec. 13, 2005 (PRIMEZONE) -- BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(tm) bone marrow derived stem cell therapeutic products for the treatment...

California Legislators Visit BrainStorm Research Facility NEW YORK and TEL AVIV, Israel, Dec. 8, 2005 (PRIMEZONE) -- BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(tm) bone marrow derived stem cell therapeutic products for the treatment...